Literature DB >> 7475223

Measurement of vascular permeability in spinal cord using Evans Blue spectrophotometry and correction for turbidity.

R E Warnick1, J R Fike, P H Chan, D K Anderson, G Y Ross, P H Gutin.   

Abstract

Vascular permeability can be visualized by Evans Blue (EB) extravasation and quantified by spectrophotometry after formamide extraction of the tissue. However, formamide extracts show significant turbidity, which may contribute to the total optical density at the wavelength of measurement (e.g., 620 lambda). We developed a simple method for estimating the component of the total optical density of a dyed specimen contributed by turbidity. Our method, which uses a determination of turbidity made at another point of the light spectrum (740 lambda), was more precise than two other EB quantification techniques. We therefore recommend it for individual correction of formamide extracts of spinal cord specimens. The application of this technique to the brain remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7475223     DOI: 10.1016/0165-0270(94)00172-d

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  9 in total

1.  IRGM3 contributes to immunopathology and is required for differentiation of antigen-specific effector CD8+ T cells in experimental cerebral malaria.

Authors:  Jintao Guo; James A McQuillan; Belinda Yau; Gregory S Tullo; Carole A Long; Patrick Bertolino; Ben Roediger; Wolfgang Weninger; Gregory A Taylor; Nicholas H Hunt; Helen J Ball; Andrew J Mitchell
Journal:  Infect Immun       Date:  2015-02-02       Impact factor: 3.441

2.  Effect of lidocaine- and prilocaine-based topical anesthetics on the inflammatory exudates in subcutaneous tissue of rats.

Authors:  Márcia Thaís Pochapski; José Laufer Neto; Jocélia Lago Jassen; Paulo Vitor Farago; Fábio André Santos
Journal:  Anesth Prog       Date:  2012

3.  Early Intravenous Delivery of Human Brain Stromal Cells Modulates Systemic Inflammation and Leads to Vasoprotection in Traumatic Spinal Cord Injury.

Authors:  Anna Badner; Reaz Vawda; Alex Laliberte; James Hong; Mirriam Mikhail; Alejandro Jose; Rachel Dragas; Michael Fehlings
Journal:  Stem Cells Transl Med       Date:  2016-05-31       Impact factor: 6.940

4.  Chronic interleukin-1beta expression in mouse brain leads to leukocyte infiltration and neutrophil-independent blood brain barrier permeability without overt neurodegeneration.

Authors:  Solomon S Shaftel; Thaddeus J Carlson; John A Olschowka; Stephanos Kyrkanides; Sarah B Matousek; M Kerry O'Banion
Journal:  J Neurosci       Date:  2007-08-29       Impact factor: 6.167

5.  ADAMTS13 ameliorates inflammatory responses in experimental autoimmune encephalomyelitis.

Authors:  Kaili Lu; Lan Liu; Xiaofeng Xu; Fei Zhao; Jiangshan Deng; Xin Tang; Xiuzhe Wang; Bing-Qiao Zhao; Xiaojie Zhang; Yuwu Zhao
Journal:  J Neuroinflammation       Date:  2020-02-19       Impact factor: 8.322

6.  A protective role for ELR+ chemokines during acute viral encephalomyelitis.

Authors:  Martin P Hosking; Liping Liu; Richard M Ransohoff; Thomas E Lane
Journal:  PLoS Pathog       Date:  2009-11-06       Impact factor: 6.823

7.  Neuroimmunological blood brain barrier opening in experimental cerebral malaria.

Authors:  Adela Nacer; Alexandru Movila; Kerstin Baer; Sebastian A Mikolajczak; Stefan H I Kappe; Ute Frevert
Journal:  PLoS Pathog       Date:  2012-10-25       Impact factor: 6.823

8.  The Th17-ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune disease.

Authors:  Thaddeus Carlson; Mark Kroenke; Praveen Rao; Thomas E Lane; Benjamin Segal
Journal:  J Exp Med       Date:  2008-03-17       Impact factor: 14.307

9.  Angiopoietin-2 blockade ameliorates autoimmune neuroinflammation by inhibiting leukocyte recruitment into the CNS.

Authors:  Zhilin Li; Emilia A Korhonen; Arianna Merlini; Judith Strauss; Eleonoora Wihuri; Harri Nurmi; Salli Antila; Jennifer Paech; Urban Deutsch; Britta Engelhardt; Sudhakar Chintharlapalli; Gou Young Koh; Alexander Flügel; Kari Alitalo
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.